Let’s take a look at the framework and key elements of market access preparedness.

The video is the launch of the Apersy YouTube channel and covers some key activities for companies that are starting to strategically developing their asset – even if they are not planning to commercialise themselves. In a world where pricing and access dynamics have just gotten more complex, the market potential of a health technology needs to be shaped early.

We have a special focus on microbiome medicines here and their specific considerations when strategically preparing patient access and reimbursement. More details with case studies can be found in our 2025 whitepaper Microbiome-targeting products: Commercial launch is moving centre stage. However, the major themes apply across highly innovative biotech products and complex indications and care delivery.